|
|
||||||||
Ann Thorac Surg 1992;54:1172-1176
© 1992 The Society of Thoracic Surgeons
a Department of Cardiopulmonary Surgery, Catharina Hospital, Eindhoven, the Netherlands
b Department of Cardiopulmonary Surgery, Research Division, University Hospital, Groningen, the Netherlands
Accepted for publication April 9, 1992.
* Address reprint requests to Dr Schönberger, Catharina Hospital, Michelangelolaan 2, 5602 ZA, PO Box 1350, Eindhoven, the Netherlands.
The effect on postoperative blood loss and blood use of blood-saving treatment with or without 280 mg of lowdose aprotinin (2 million kallikrein inactivator units) was studied in 200 consecutive patients undergoing either unilateral or bilateral internal mammary artery bypass grafting. Postoperative blood loss and total units of homologous blood products were similar in patients having either bypass procedure without aprotinin treatment. In patients given aprotinin, postoperative blood loss and use of homologous blood products were significantly lower (p < 0.05). The use of any donor blood product was prevented in 78% of the patients given aprotinin versus only 45% of patients treated without aprotinin. None of the aprotinin-treated patients under went repeat thoracotomy for excessive bleeding; repeat thoracotomy was indicated in 8% of the patients having bilateral internal mammary artery grafting without aprotinin treatment. These results demonstrate that low-dose aprotinin reduces blood loss and blood use significantly and prevents excessive bleeding.
This article has been cited by other articles:
![]() |
E. Ovrum, G. Tangen, S. Tollofsrud, M.-A. L. Ringdal, R. Oystese, and R. Istad Low postoperative dose of aprotinin reduces bleeding and is safe in patients receiving clopidogrel before coronary artery bypass surgery. A prospective randomized study Interact CardioVasc Thorac Surg, April 1, 2010; 10(4): 545 - 548. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. E. Firanescu, E. J. Martens, J. P. A. M. Schonberger, M. A. Soliman Hamad, and A. H. M. van Straten Postoperative blood loss in patients undergoing coronary artery bypass surgery after preoperative treatment with clopidogrel. A prospective randomised controlled study Eur J Cardiothorac Surg, November 1, 2009; 36(5): 856 - 862. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Rupinder, V. Manimozhi, G. Nagaraj, K. Vasanth, K. B. Sanjay, C. John, and K. Muralidhar Aprotinin for Open Cardiac Surgery in Cyanotic Heart Disease Asian Cardiovasc Thorac Ann, June 1, 2001; 9(2): 101 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. J. Ray, K. F. Brown, C. A. Burrows, and M. F. O Brien Economic evaluation of high-dose and low-dose aprotinin therapy during cardiopulmonary bypass Ann. Thorac. Surg., September 1, 1999; 68(3): 940 - 945. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Dietrich, K. Schopf, M. Spannagl, M. Jochum, S. L. Braun, and H. Meisner Influence of High- and Low-Dose Aprotinin on Activation of Hemostasis in Open Heart Operations Ann. Thorac. Surg., January 1, 1998; 65(1): 70 - 77. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Westaby Aprotinin Fifteen Years Later Seminars in Cardiothoracic and Vascular Anesthesia, November 1, 1997; 1(4): 366 - 375. [Abstract] [PDF] |
||||
![]() |
R. R. Lazzara, F. E. Kidwell, M. F. Kraemer, J. A. Wood, and A. Starr Reduction in Costs, Blood Products, and Operating Time in Patients Undergoing Open Heart Surgery Arch Surg, August 1, 1997; 132(8): 858 - 861. [Abstract] [PDF] |
||||
![]() |
J. H. Lemmer Jr, E. W. Dilling, J. R. Morton, J. B. Rich, F. Robicsek, D. L. Bricker, C. B. Hantler, J. G. Copeland III, J. L. Ochsner, P. O. Daily, et al. Aprotinin for Primary Coronary Artery Bypass Grafting: A Multicenter Trial of Three Dose Regimens Ann. Thorac. Surg., December 1, 1996; 62(6): 1659 - 1668. [Abstract] [Full Text] |
||||
![]() |
Y. J. Gu, J. de Haan, U. P. M. Brenken, W. J. de Boer, Jm. Prop, W. van Oeveren, and G. L. T. Group CLOTTING AND FIBRINOLYTIC DISTURBANCE DURING LUNG TRANSPLANTATION: EFFECT OF LOW-DOSE APROTININ J. Thorac. Cardiovasc. Surg., September 1, 1996; 112(3): 599 - 606. [Abstract] [Full Text] |
||||
![]() |
G. E. Hill, A. Alonso, J. R. Spurzem, A. H. Stammers, and R. A. Robbins APROTININ AND METHYLPREDNISOLONE EQUALLY BLUNT CARDIOPULMONARY BYPASS-INDUCED INFLAMMATION IN HUMANS J. Thorac. Cardiovasc. Surg., December 1, 1995; 110(6): 1658 - 1662. [Abstract] [Full Text] |
||||
![]() |
J. H. Levy, R. Pifarre, H. V. Schaff, J. C. Horrow, R. Albus, B. Spiess, T. K. Rosengart, J. Murray, R. E. Clark, P. Smith, et al. A Multicenter, Double-Blind, Placebo-Controlled Trial of Aprotinin for Reducing Blood Loss and the Requirement for Donor-Blood Transfusion in Patients Undergoing Repeat Coronary Artery Bypass Grafting Circulation, October 15, 1995; 92(8): 2236 - 2244. [Abstract] [Full Text] |
||||
![]() |
D. Green, J. Sanders, M. Eiken, C. A. Wong, J. Frederiksen, A. Joob, A. Palmer, A. Trowbridge, B. Woodruff, M. Moerch, et al. RECOMBINANT APROTININ IN CORONARY ARTERY BYPASS GRAFT OPERATIONS J. Thorac. Cardiovasc. Surg., October 1, 1995; 110(4): 963 - 970. [Abstract] [Full Text] |
||||
![]() |
J. P. A. M. Schonberger, P. A. M. Everts, and J. J. Hoffmann Systemic blood activation with open and closed venous reservoirs Ann. Thorac. Surg., June 1, 1995; 59(6): 1549 - 1555. [Abstract] [PDF] |
||||
![]() |
E. Berreklouw, J. P. A. M. Schonberger, J. H. Bavinck, V. J. Verwaal, E. L. Koldewijn, F. van Der Linden, I. Van der Tweel, and J. J. Bredee Similar hospital morbidity with the use of one or two internal thoracic arteries Ann. Thorac. Surg., June 1, 1994; 57(6): 1564 - 1572. [Abstract] [PDF] |
||||
![]() |
P. A. M. Everts, E. Berreklouw, M. M. M. Hessels, and J. P. A. M. Schonberger Continuous retrograde hypothermic low flow cerebral perfusion during aortic arch surgery Perfusion, March 1, 1994; 9(2): 95 - 99. [Abstract] [PDF] |
||||
![]() |
K. M. Taylor Perioperative approaches to coagulation defects Ann. Thorac. Surg., November 1, 1993; 56(5_suppl_1): S78 - S82. [Abstract] [PDF] |
||||
![]() |
J. P. A. M. Schonberger, J. J. Bredee, D. Tjian, P. A. M. Everts, and C. R. H. Wildevuur Intraoperative predonation contributes to blood saving Ann. Thorac. Surg., October 1, 1993; 56(4): 893 - 898. [Abstract] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |